Cibus Biotechnologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cibus Biotechnologies's estimated annual revenue is currently $2.8M per year.(i)
  • Cibus Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Cibus Biotechnologies has 18 Employees.(i)
  • Cibus Biotechnologies grew their employee count by 50% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M5-17%N/AN/A
#2
$1.4M9-10%N/AN/A
#3
$5.9M3841%N/AN/A
#4
$1.1M7-53%N/AN/A
#5
$1.6M1011%N/AN/A
#6
$21.2M13710%N/AN/A
#7
$1.6M33-48%$17.8MN/A
#8
$1.9M120%N/AN/A
#9
$3.7M249%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is Cibus Biotechnologies?

Cibus Biotechnologies is a food safety company dedicated to protecting the worlds food supply through state-of-the-art diagnostic and tracking platform and therapeutics for treatment of animal diseases. The Cibus diagnostic platform consists of a portable, simple, inexpensive device capable of testing virtually anything relating to food safety or animal diseases. Validated assays do not require refrigeration and dramatically speed up testing time. The platform also includes cloud-based storage for tracking test results and providing information into software-based quality management systems in real-time. Unlike standard lab-based testing, the Cibus system provides results within 30 minutes or less, using patented, award winning (FDA’s Food Safety Challenge competition), and validated technology. When fully developed, our Diagnostic Platform will enable testing at any point in the food supply chain and in any location in the world. With the ability to perform multiple tests for different pathogens simultaneously for less cost than competitors can perform a single test.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M186%N/A
#2
$1.6M18-5%N/A
#3
$2.7M18N/AN/A
#4
$3.5M186%N/A
#5
$2.9M1820%N/A